Abstract
Background: Transitional Age Youth (TAY), the period between 15-25 years old, is now recognized as a unique developmental stage and a highly vulnerable time period for the onset of Serious Mental Illness (SMI).
Objective: The study aimed to inform readers about TAY with SMI to improve recognition of their developmental needs and improve patient care.
Methods: The authors describe their work with TAY experiencing SMI on inpatient psychiatric units by citing case examples that illustrate individual treatment issues, the level of family involvement in care, and social/systems based practice.
Results: TAY patients with SMI are more likely to adhere to ongoing psychiatric care when their developmental needs are addressed while in an acute inpatient setting.
Conclusion: Focusing on mental health needs of TAY while applying a developmental perspective can improve patient care and compliance to treatment.
Keywords: Transitional Age Youth (TAY), Serious Mental Illness (SMI), developmental perspective, biopsychosocial formulation, treatment issues, clinical case.
Adolescent Psychiatry
Title:Transitional Age Youth with Serious Mental Illness: High Acuity Patients Requiring Developmentally Informed Care in the Inpatient Hospital Setting
Volume: 8 Issue: 3
Author(s): Timothy Van Deusen*, Cynthia Wilson, Hyun Jung Kim, Zheala Qayyum, Hun Millard and Susan Parke
Affiliation:
- Department of Psychiatry, Yale School of Medicine, West Haven Mental Health Clinic, 270 Center St., West Haven, CT,United States
Keywords: Transitional Age Youth (TAY), Serious Mental Illness (SMI), developmental perspective, biopsychosocial formulation, treatment issues, clinical case.
Abstract: Background: Transitional Age Youth (TAY), the period between 15-25 years old, is now recognized as a unique developmental stage and a highly vulnerable time period for the onset of Serious Mental Illness (SMI).
Objective: The study aimed to inform readers about TAY with SMI to improve recognition of their developmental needs and improve patient care.
Methods: The authors describe their work with TAY experiencing SMI on inpatient psychiatric units by citing case examples that illustrate individual treatment issues, the level of family involvement in care, and social/systems based practice.
Results: TAY patients with SMI are more likely to adhere to ongoing psychiatric care when their developmental needs are addressed while in an acute inpatient setting.
Conclusion: Focusing on mental health needs of TAY while applying a developmental perspective can improve patient care and compliance to treatment.
Export Options
About this article
Cite this article as:
Van Deusen Timothy*, Wilson Cynthia, Kim Jung Hyun, Qayyum Zheala, Millard Hun and Parke Susan, Transitional Age Youth with Serious Mental Illness: High Acuity Patients Requiring Developmentally Informed Care in the Inpatient Hospital Setting, Adolescent Psychiatry 2018; 8 (3) . https://dx.doi.org/10.2174/2210676608666180820153318
DOI https://dx.doi.org/10.2174/2210676608666180820153318 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Intriguing Occurrence of Segmental Arterial Mediolysis: Case Report and Concise Literature Review
Cardiovascular & Hematological Disorders-Drug Targets Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators
Current Topics in Medicinal Chemistry The Neuroimmunoendocrine Network in the Complex Host-Parasite Relationship During Murine Cysticercosis
Current Topics in Medicinal Chemistry Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
CNS & Neurological Disorders - Drug Targets Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma
Current Drug Safety Amyloid-Targeted Metal Chelation, Anti-Oxidative Stress, and Anti- Inflammation as Potential Alzheimers Therapies
Current Bioactive Compounds GEPT Extract Reduces Aβ Deposition by Regulating the Balance Between Production and Degradation of Aβ in APPV717I Transgenic Mice
Current Alzheimer Research Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
Current Medicinal Chemistry Giardiasis: Recent Progress in Chemotherapy and Drug Development (Hot Topic: Anti-Infective Agents Executive Editors: Mitchell A. Avery / Vassil St.) Georgiev
Current Pharmaceutical Design The Role of Phosphorylation in Synucleinopathies: Focus on Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders
Current Alzheimer Research Use of Telemetry Blood Pressure Transmitters to Measure Intracranial Pressure (ICP) in Freely Moving Rats
Current Neurovascular Research Potential Application of Centrifuges to Protect the CNS in Space and on Earth
Current Alzheimer Research Pulmonary Infections in the Era of Biological Agents
Current Respiratory Medicine Reviews A Fluorescent Anti-Cancer Agent, 3,6-bis(1-methyl-4-vinylpyridinium) Carbazole Diiodide, Stains G-Quadruplexes in Cells and Inhibits Tumor Growth
Current Topics in Medicinal Chemistry The Novartis Compound Archive - From Concept to Reality
Combinatorial Chemistry & High Throughput Screening From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Current Immunology Reviews (Discontinued) The <i>locus</i> of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms
CNS & Neurological Disorders - Drug Targets Microgravity Alters Cancer Growth and Progression
Current Cancer Drug Targets Diagnosing and Treating Depression in Older and Oldest Old
Current Pharmaceutical Design